1408. Population Pharmacokinetic (PK) Model to Describe Epithelial Lining Fluid (ELF) Penetration of ASN-1 and ASN-2 after ASN100 Administration to Healthy Subjects

著者: Van Wart, Scott A, Stevens, Christopher, Magyarics, Zoltan, Luperchio, Steven A, Rubino, Christopher M, Ambrose, Paul G
出版年 Open Forum Infect Dis (2018)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

著者: Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
出版事項 2009

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

著者: Andes, David R., Reynolds, Daniel K., Van Wart, Scott A., Lepak, Alexander J., Kovanda, Laura L., Bhavnani, Sujata M.
出版事項 2013

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

著者: Trang, Michael, Seroogy, Julie D., Van Wart, Scott A., Bhavnani, Sujata M., Kim, Aryun, Gibbons, Jacqueline A., Ambrose, Paul G., Rubino, Christopher M.
出版年 Antimicrob Agents Chemother (2019)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptoc...

著者: Van Wart, Scott A., Ambrose, Paul G., Rubino, Christopher M., Khariton, Tatiana, Riccobene, Todd A., Friedland, H. David, Critchley, Ian A., Bhavnani, Sujata M.
出版事項 2014

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

著者: Andes, David, Ambrose, Paul G., Hammel, Jeffrey P., Van Wart, Scott A., Iyer, Varsha, Reynolds, Daniel K., Buell, Donald N., Kovanda, Laura L., Bhavnani, Sujata M.
出版事項 2011

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

著者: Lakota, Elizabeth A., Van Wart, Scott A., Trang, Michael, Tzanis, Evan, Bhavnani, Sujata M., Safir, M. Courtney, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Rubino, Christopher M.
出版年 Antimicrob Agents Chemother (2020)

Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics

著者: Kamal, Mohamed A., Van Wart, Scott A., Rayner, Craig R., Subramoney, Vishak, Reynolds, Daniel K., Bulik, Catharine C., Smith, Patrick F., Bhavnani, Sujata M., Ambrose, Paul G., Forrest, Alan
出版事項 2013

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

著者: Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
出版事項 2013

Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients with Acute Bacterial Skin and Skin Structure Infections

著者: Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Drusano, George L., Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
出版年 Antimicrob Agents Chemother (2014)

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes

著者: Schiffer, Joshua T., Swan, David A., Magaret, Amalia, Corey, Lawrence, Wald, Anna, Ossig, Joachim, Ruebsamen-Schaeff, Helga, Stoelben, Susanne, Timmler, Burkhard, Zimmermann, Holger, Melhem, Murad R., Van Wart, Scott A., Rubino, Christopher M., Birkmann, Alexander
出版年 Sci Transl Med (2016)

Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

著者: Thwaites, Guy E., Bhavnani, Sujata M., Chau, Tran Thi Hong, Hammel, Jeffrey P., Török, M. Estée, Van Wart, Scott A., Mai, Pham Phuong, Reynolds, Daniel K., Caws, Maxine, Dung, Nguyen Thi, Hien, Tran Tinh, Kulawy, Robert, Farrar, Jeremy, Ambrose, Paul G.
出版事項 2011